Terazosin Used for ALS Extended Survival in Animal Models in Early...

Terazosin Used for ALS Extended Survival in Animal Models in Early...

ALS News Today - 24 Aug 2022
The approved blood pressure medication terazosin protected motor neurons in animal models of ALS and may be "an exciting potential therapy."

SBU Research Team Developing a Robot to Help ALS Patients - SBU News

Stony Brook News - 26 Apr 2024
SBU Research Team Developing a Robot to Help ALS Patients - SBU News ...

Improving access to care for rural ALS patients: "How can we make it easier?"

KBIA - 26 Apr 2024
Improving access to care for rural ALS patients: "How can we make it easier?" ...

Interview: Steve Gleason, the author of the A.L.S. memoir ‘A Life Impossible’

The New York Times - 25 Apr 2024
Interview: Steve Gleason, the author of the A.L.S. memoir ‘A Life Impossible’ ...

ALS disease progression slowed in real-world setting with Qalsody

ALS News Today - 25 Apr 2024
ALS disease progression slowed in real-world setting with Qalsody ...

Combination ALS therapeutic nonsuperior to placebo in phase 3 clinical trial

Healio - 26 Apr 2024
Combination ALS therapeutic nonsuperior to placebo in phase 3 clinical trial ...

Mosaic Art Take & Create Kits available at ALS Libraries May 7-31

Mesabi Tribune - 27 Apr 2024
Mosaic Art Take & Create Kits available at ALS Libraries May 7-31 ...

Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression

Medical Xpress - 26 Apr 2024
Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression ...

ALS Awareness game personal for West

Spectrum News 1 - 26 Apr 2024
ALS Awareness game personal for West ...

Amylyx May Pull FDA-Approved ALS Drug After Failed Phase 3 Trial

Medscape - 08 Mar 2024
Amylyx May Pull FDA-Approved ALS Drug After Failed Phase 3 Trial ...

Coya Therapeutics CEO Discusses Next Steps Amid Positive Results from Coya 302 Trial for ALS Treatment

Pharmaceutical Executive - 24 Apr 2024
Coya Therapeutics CEO Discusses Next Steps Amid Positive Results from Coya 302 Trial for ALS Treatment ...

Bob Scott: Volunteering to Make it a Little Bit More Fair

ALS Association - 26 Apr 2024
Bob Scott: Volunteering to Make it a Little Bit More Fair ...

Here's Why ALS Drug Relyvrio Is Being Removed From Market—And What That Means For Patients

Forbes - 04 Apr 2024
Here's Why ALS Drug Relyvrio Is Being Removed From Market—And What That Means For Patients ...

ALS Life Expectancy: Prognosis and Treatment Options

Verywell Health - 21 Apr 2024
ALS Life Expectancy: Prognosis and Treatment Options ...

U.K. decision on ALS drug has neurologists, advocates up in arms

STAT - 01 Apr 2024
U.K. decision on ALS drug has neurologists, advocates up in arms ...

Validating A Better ALS Biomarker With Coya's Fred Grossman

Clinical Leader - 24 Apr 2024
Validating A Better ALS Biomarker With Coya's Fred Grossman ...

'Debbie's All-Stars' hockey tournament raises funds for ALS in Liverpool woman's memory

CNYcentral.com - 26 Apr 2024
'Debbie's All-Stars' hockey tournament raises funds for ALS in Liverpool woman's memory ...

ETSU ALS clinic wins $75K grant to expand its free care services

ALS News Today - 26 Apr 2024
ETSU ALS clinic wins $75K grant to expand its free care services ...

How being outdoors brought peace and perspective, then and now

ALS News Today - 26 Apr 2024
How being outdoors brought peace and perspective, then and now ...

Phase 2 trial testing dazucorilant in ALS patients now fully enrolled

ALS News Today - 24 Apr 2024
Phase 2 trial testing dazucorilant in ALS patients now fully enrolled ...

ALS